Medical Research
Follow Medical Research in the Factlen app and get an alert when there is news. Get the app
- All Health
- Nutrition & Diet
- Supplements
- Mental Health
- Sleep
- Longevity
- Medicine
- Medications & Treatments
- Conditions & Diseases
- Hormones & Endocrinology
- Skincare
- Dental Health
- Family Health
- Children's Health
- Men's Health
- Women's Health
- Aging & Geroscience
- Biohacking
- Alternative Medicine
- Public Health
- Medical Research
- Preventive Wellness
- Healthy Habits
Explainer
Harvard Researchers Discover Chimeric mRNAs in Mammals, Revealing a Hidden Layer of the Immune System
3 sources · 49d ago
Celiac Disease
Teva's Anti-IL-15 Antibody Halts Intestinal Damage in Phase 2a Celiac Trial
5 sources · 46d ago
Sleep Apnea
Once-Nightly Pill Cuts Sleep Apnea Interruptions by 44% in Phase 3 Trial
2 sources · 50d ago
More in Medical Research
Genome ArchitectureMedical Breakthrough
Researchers Discover Alzheimer's Disease Disrupts the 3D Architecture of DNA in Brain Cells
Computational Biologists 40%Clinical Neurologists 35%Aging Researchers 25%
Diabetes ManagementClinical Trial
8-Hour Eating Window Safely Improves Blood Sugar Control in Adults with Type 1 Diabetes
Clinical Researchers 40%Endocrinologists and Care Providers 40%Patient Advocates 20%
Multiple SclerosisClinical Trial Results
Oral BTK Inhibitor Remibrutinib Shows Superiority in Phase 3 Multiple Sclerosis Trials
Clinical Researchers 40%Pharmaceutical Industry 35%Patient Advocates 25%
ExplainerGenetic Engineering
The Core Mechanics of CRISPR-Cas9: How Guide RNA and Cas9 Enable Precise Gene Editing
Molecular Biologists 40%Clinical Geneticists 40%Bioethicists 20%
Essential ThrombocythemiaTreatment Breakthrough
FDA Approves First Essential Thrombocythemia Drug in 30 Years, Targeting Underlying Disease
Clinical Hematologists 45%Patient Advocacy Groups 35%Oncology Nursing Community 20%
Cardiology ResearchClinical Trial Results
PCSK9 Inhibitor Repatha Cuts All-Cause Death Risk by 20% in High-Risk Primary Prevention Patients
Clinical Researchers 50%Industry Analysts 30%Factlen Editorial Team 20%
ExplainerStructural Biology
Thermodynamics and Hydrophobic Collapse: How Amino Acid Chains Fold in Milliseconds
Thermodynamic Determinists 35%Cellular Biologists 35%Computational Biologists 30%
ExplainerVaccine Technology
mRNA Vaccines: Lipid Nanoparticle Delivery and Rapid Cellular Degradation
Immunological Researchers 35%Public Health Officials 35%Pharmaceutical Industry 30%
ExplainerStatistical Methods
Why Modern Research Relies on Effect Sizes and Confidence Intervals Over P-Values
Replication Reformers 45%Clinical Practitioners 35%Traditional Frequentists 20%
ExplainerCausal Inference
Distinguishing Correlation From Causation Through Randomized and Quasi-Experiments
Clinical Purists 40%Applied Econometricians 35%Data Scientists 25%
ExplainerCardiovascular Health
The Biological Mechanism of Heart Attacks: Why Inflammation is as Dangerous as Cholesterol
Inflammation-First Cardiologists 40%Traditional Lipidologists 40%Environmental Health Advocates 20%
Dietary SweetenersRisk Analysis
Common Sweetener Xylitol Linked to 57% Higher Risk of Heart Attack and Stroke in Landmark Study
Cardiovascular Researchers 40%Public Health Advocates 40%Dental Professionals 20%
ExplainerCancer Screening
Data From 140,000-Person Trial Paves Way for Single Blood Test to Screen for 50 Cancers
Early Detection Advocates 40%Methodology Skeptics 30%Public Health Evaluators 30%
ExplainerPrecision Oncology
How AI-Guided Biomarker Discovery is Rewriting the Odds of Cancer Survival
Computational Pathologists 40%Clinical Oncologists 35%Trial Designers 25%
Cardiovascular HealthRegulatory Approval
FDA Approves Mounjaro to Reduce Heart Attack and Stroke Risk in Type 2 Diabetes Patients
Medical Consensus 50%Industry Analysts 30%Clinical Practitioners 20%
ExplainerImmunotoxicology
Does the Microplastic-Autoimmune Link Prove the FDA's Chemical-Centric Regulatory Model is Obsolete?
Immunologists & Pathologists 44%Federal Regulatory Agencies 28%Industry & Manufacturing Advocates 28%
Liver DiseaseClinical Trial
Clinical Trial Finds Keto Diet Cuts Liver Fat by 67%, Outperforming Mediterranean Diet for MASLD
Clinical Researchers 40%Public Health Advocates 30%General Wellness Observers 30%
ExplainerPulmonary Rehab
Low-Load Blood Flow Restriction Training Reduces Ventilatory Stress in COPD Patients, Opening New Rehab Pathway
Clinical Researchers 40%Pulmonary Rehabilitation Specialists 35%COPD Patients 25%
Alzheimer's ResearchScientific Breakthrough
Alzheimer's Structural Brain Changes Begin 7 Years Before Visible Amyloid Plaques, Study Finds
Diagnostic Innovators 40%Amyloid Skeptics 35%Clinical Practitioners 25%
Polycythemia VeraDrug Approval
FDA Approves Mimrylo as First-in-Class Treatment for Rare Blood Cancer Polycythemia Vera
Clinical Hematologists 40%Industry Analysts 30%Drug Developers 30%
ExplainerSickle Cell Disease
First-Ever In Vivo Imaging Captures Sickle Cell Vaso-Occlusive Events in Real Time
Clinical Hematologists 40%Biomedical Engineers 30%Patient Advocates 30%
Gene TherapyClinical Trial
Single-Dose CRISPR Gene Therapy Safely Lowers LDL Cholesterol by 52.5% After One Year in Phase 1 Trial
Clinical Researchers 40%Therapeutics Developers 30%Patient Care Advocates 30%
Genetic MedicineScientific Breakthrough
Engineered tRNA Therapeutic Could Treat Thousands of Genetic Diseases by Correcting Nonsense Mutations
Genetic Medicine Researchers 40%Biotech Industry Analysts 35%tRNA Therapeutics Developers 25%
Synthetic BiologyEvidence Pack
Engineered Cell-Free System Creates Proteins With 34 Amino Acids, Overturning Decades of Genetic Code Understanding
Synthetic Biologists 40%Evolutionary Geneticists 35%Biosafety Advocates 25%
Autoimmune BreakthroughClinical Trial Results
CAR T-Cell Therapy Successfully Reverses Severe Rheumatoid Arthritis in Landmark Study
Clinical Researchers 40%Rheumatology Specialists 35%Patient Advocates 25%
Synaptic PlasticityScientific Breakthrough
Discovery of 'Local Protein Translation' Fundamentally Rewrites How Neurons Form Connections
Cellular Neuroscientists 40%Translational Researchers 35%Structural Biologists 25%
ExplainerGastric Cancer
FDA Approves Dual-Targeted Therapy for HER2-Positive Gastric Cancer First-Line Treatment
Clinical Oncologists 40%Regulatory Authorities 30%Medical Analysts 30%
Pancreatic CancerTreatment Breakthrough
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer, Nearly Doubling Survival
Clinical Researchers 50%Patient Advocates 50%
ExplainerRare Diseases
FDA Approves Imaavy as First-Ever Treatment for Life-Threatening Autoimmune Disease wAIHA
Clinical Hematologists 40%Rare Disease Advocates 35%Regulatory Monitors 25%
Rectal CancerMedical Breakthrough
Landmark Trial Finds Chemoradiotherapy Spares 80% of Rectal Cancer Patients From Major Surgery and Colostomy
Clinical Researchers 50%Surgical Oncologists 30%Patient Advocacy Groups 20%
Nutrition PolicyGuideline Shift
New Federal Dietary Guidelines Double Protein Recommendation, Endorse Full-Fat Dairy
Federal Health Officials 40%Cardiovascular Health Advocates 35%Nutrition Researchers 25%
ExplainerMetabolic Science
Experimental Compound TOFA Promotes Fat Loss While Preserving Muscle in Mice
Metabolic Researchers 40%Clinical Practitioners 35%Pharmaceutical Developers 25%
In Vivo CRISPRClinical Milestone
First-Ever Phase 3 Success for In Vivo CRISPR Therapy Achieved, Paving Way for New Class of Medicine
Genetic Medicine Advocates 45%Clinical Realists 30%Market Analysts 25%
ExplainerMuscle Biology
Molecular Mystery Solved: Protein Leiomodin Unlocks New Mechanism for Building Muscle Actin Filaments
Molecular Biologists 40%Clinical Geneticists 35%Exercise Physiologists 25%
ExplainerDrug Regulation
FDA Finalizes 'Human-Centric' Guidance, Formally Shifting Drug Approval Away From Animal Testing
Biotech Innovators 40%Traditional Pharmacologists 30%Animal Welfare Advocates 30%
Research BriefAI Capabilities
Data Analysis Reveals AI Systems Outperforming Doctors in Triage and Writing Peer-Reviewed Papers
Techno-Optimists 40%Clinical Realists 35%Academic Skeptics 25%
CKM SyndromeGuideline Update
Landmark Guideline from Four Major Societies Defines New 'Cardiovascular-Kidney-Metabolic Syndrome'
Guideline Authors 60%Primary Care Providers 25%Public Health Advocates 15%
AnalysisCancer Research
FDA Approves Vepdegestrant, First-in-Class PROTAC Drug, Ushering in New Era of Targeted Cancer Therapy
Oncology Researchers 40%Clinical Practitioners 35%Patient Advocates 25%
Pediatric NeurologyTreatment Trade-Offs
FDA Grants Priority Review to Ecopipam, First Novel-Mechanism Drug for Pediatric Tourette Syndrome in 50 Years
Ecopipam Investigators 50%Clinical Neurologists 30%Pharmacy Analysts 20%
Alzheimer's DiseaseClinical Trial
New Tau-Targeting Drug Halves Cognitive Decline in Alzheimer's Phase 2 Trial
Clinical Researchers 40%Alzheimer's Advocacy Groups 30%Cautious Analysts 30%
AnalysisMotor Circuitry
Discovery That Key Cerebellar Cells Are Not Tightly Linked Forces Rewrite of Movement Disorder Research
Motor Circuitry Researchers 45%Clinical Neurologists 35%Factlen Editorial Team 20%
Blood SafetyResearch Review
Lancet Review Suggests Alzheimer's Proteins May Be Transmitted Via Blood Transfusions
Clinical Investigators 45%Patient Safety Advocates 45%Editorial Synthesis 10%
Gut HealthDietary Compare
When Superfoods Hurt: UNC Study Links Oxalates in Spinach and Almonds to Worsened Gut Inflammation
Gastroenterology Researchers 40%Clinical Dietitians 35%Integrative Health Practitioners 25%
ExplainerNerve Regeneration
How Muscle Contraction Directly Stimulates Nerve Growth (And What It Means for Repair Therapies)
Clinical Researchers 50%Physical Therapists 50%
ExplainerCardiac Regeneration
Stem Cell Therapy Reverses Severe Heart Failure in 90% of Patients in Landmark Phase 2 Trial
Clinical Researchers 40%Cardiac Electrophysiologists 35%Healthcare Economists 25%
NeuroimmunologyBreakthrough Discovery
Newly Discovered 'Immune Organ' Inside Skull Directs Brain Defense, Rewriting Neuroimmunology
Neuroimmunologists 40%Oncology Researchers 35%Clinical Neurologists 25%
Per page

















































